Epidemiology of Injuries in the Professional Women's Swedish National IceHockey League Permitted to Body-Checking
Launched by LUND UNIVERSITY · Apr 2, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying injuries that happen to professional female ice hockey players in Sweden, particularly those who are allowed to body-check during games. By understanding the types and causes of these injuries, researchers hope to help doctors better diagnose and treat them. The information gathered could also lead to safer practices in the sport, such as improved training programs and better equipment, ultimately aiming to reduce the number and severity of injuries. This study is important because it focuses on female athletes, a group that hasn't been extensively researched in sports medicine.
To be eligible for this trial, participants need to be at least 16 years old and currently playing in the top Swedish women’s ice hockey league. Those who join the study can expect to share information about their experiences with injuries, which will help researchers learn more about how to keep athletes safe. Overall, this research aims to improve the health and well-being of female athletes not just in hockey, but in various sports.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • minimum 16 years of age, registered player in the highest Swedish professional ice hockey league for women, SDHL
- Exclusion Criteria:
- • age under 16 years.
About Lund University
Lund University, a prestigious research institution in Sweden, is renowned for its commitment to advancing scientific knowledge and innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at addressing critical health challenges. Leveraging its state-of-the-art facilities and a diverse network of expert researchers, Lund University strives to translate research findings into effective therapeutic solutions, ultimately improving patient outcomes and enhancing public health. Through its dedication to ethical research practices and patient safety, Lund University plays a pivotal role in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malmö, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported